If you enjoy this content, please share it with a colleague
RELATED CONTENT
June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...
Janaury 10, 2022 — The Department of Energy’s National Nuclear Security Administration (NNSA) and Office of ...
March 26, 2021 — Shine Medical Technologies LLC announced that construction of the exterior structure of its first-of-a ...
December 18, 2020 — SHINE Medical Technologies LLC today announced that the company has broken ground on a new 54,000 ...
Medical imaging procedures such as single-photon emission computed tomography (SPECT) scans, myocardial perfusion scans ...
October 28, 2019 — Phoenix LLC and Shine Medical Technologies LLC, nuclear technology companies focused on near-term ...
Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in Janesville, Wis. U.S. Department of Energy (DOE) Under Secretary for Nuclear Security and Administrator of the National Nuclear Security Administration (NNSA) Lisa Gordon-Hagerty, Lantheus Medical Imaging President and CEO Mary Heino and Janesville City Manager Mark Freitag joined Shine founder and CEO, Greg Piefer, and the Shine team to celebrate the milestone.
March 1, 2016 — Wisconsin-based Shine Medical Technologies Inc., producer of medical tracers and cancer treatment ...
Lantheus Medical Imaging Inc. and Shine Medical Technologies Inc. announced that the companies have entered into a strategic agreement for the future supply of molybdenum-99 (Mo-99). The supply agreement marks Lantheus’ first with a prospective United States supplier of Mo-99.